mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.2 |
mRNA |
HG-6-64-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
MG-132 |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.2 |
mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.2 |
mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.2 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |